Subscribe to RSS
DOI: 10.1055/s-2004-831844
© Georg Thieme Verlag Stuttgart · New York
Varizellen in der Schwangerschaft
Teil 2: Diagnostik, Prophylaxe und Therapie[1] Varicella during pregnancyPart 2: Diagnosis, prevention and therapyPublication History
eingereicht: 19.3.2004
akzeptiert: 22.7.2004
Publication Date:
22 September 2004 (online)

Zusammenfassung
Varizellen gehören zu den gefürchteten Infektionen während der Schwangerschaft. Aufgrund einer möglichen Prophylaxe durch Impfung sind die Folgen mütterlicher Varizellen für das Kind von besonderem Interesse. Als Teil 2 gibt die vorliegende Arbeit einen Überblick über die derzeitigen Möglichkeiten der Diagnostik, Prophylaxe und Therapie von Varicella-Zoster-Virus-Infektionen während der Schwangerschaft.
Summary
Varicella belongs to serious infections during pregnancy. After introduction of prophylaxis by vaccination, there is a particular interest to learn more about the consequences of maternal varicella for the infant. As part 2, the present paper reviews the current possibilities of diagnosis, prevention and therapy of varicella-zoster virus infections during pregnancy.
1 Der Beitrag „Varizellen in der Schwangerschaft. Teil 1: Epidemiologie und Klinik” ist im vorhergehenden Heft (Nr. 38) erschienen.
Literatur
- 1
Akisu M, Yalez M, Aksu G. et al .
Maternally acquired varicella-zoster virus antibodies disappear at 6 months
of age in prematurely born children.
Panminerva Med.
2003;
45
155-6
Reference Ris Wihthout Link
- 2
Andrews E B.
Acyclovir does not increase risk in pregnancy.
Am Pharm.
1994;
NS34
6
Reference Ris Wihthout Link
- 3
Carter P E et al.
Neonatal varicella infection.
Lancet.
1986;
2
1459-60
Reference Ris Wihthout Link
- 4 Deutsche Gesellschaft für Pädiatrische Infektologie .Handbuch 2003: Infektionen im Kindesalter. 4. Auflage. München; Futuramed 2003: 732-9
Reference Ris Wihthout Link
- 5 Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. Arvin AM, Gershon AA Varicella-zoster virus. Virology and clinical management Cambridge; University Press 2000: 317-47
Reference Ris Wihthout Link
- 6 Gershon A A. Varicella-zoster virus. Feigin RD, Cherry JD Textbook of pediatric infectious diseases. 4th edition Philadelphia; W. B. Saunders Company 1998: 1769-77
Reference Ris Wihthout Link
- 7
Gershon A A, Raker R. et al .
Antibody to varicella-zoster virus in parturient women and their offspring during
the first year of life.
Pediatrics.
1976;
58
692-6
Reference Ris Wihthout Link
- 8
Johansson A B, Rassart A, Blum D. et al .
Lower-limb hypoplasia due to intrauterine infection with herpes simplex virus
type 2: possible confusion with intrauterine varicella-zoster syndrome.
Clin Infect Dis.
2004;
38
e57-62
Reference Ris Wihthout Link
- 9
Koskimies O, Lapinleimu K, Saxén L.
Infections and other maternal factors as risk indicators for congenital malformations:
a case-control study with paired serum samples.
Pediatrics.
1978;
61
832-7
Reference Ris Wihthout Link
- 10
Michie C A, Acolet D, Charlton R. et al .
Varicella-zoster contracted in the second trimester of pregnancy.
Pediatr Infect Dis J.
1992;
11
1050-3
Reference Ris Wihthout Link
- 11
Miller E.
Varicella-zoster virus infection in pregnancy.
Arch Dis Childh.
1994;
70
F157-8
Reference Ris Wihthout Link
- 12
Ogilvie N M.
Antiviral prophylaxis and treatment in chickenpox. A review prepared for the
UK Advisory Group on Chickenpox on behalf of the British Society for the Study
of Infection.
J Infect.
1998;
36 Suppl 1
31-8
Reference Ris Wihthout Link
- 13
Paulman P M, McLellan R.
Varicella during pregnancy: the timing of effective treatment.
J Am Board Fam Pract.
1990;
3
121-3
Reference Ris Wihthout Link
- 14
Pretorius D H, Hayward I, Jones K L. et al .
Sonographic evaluation of pregnancies with maternal varicella infection.
J Ultrasound Med.
1992;
11
459-63
Reference Ris Wihthout Link
- 15
Prober C G, Gershon A A, Grose C. et al .
Consensus: varicella-zoster infections in pregnancy and the perinatal period.
Pediatr Infect Dis J.
1990;
9
865-9
Reference Ris Wihthout Link
- 16
Salzman M B, Sharrar R G. et al .
Transmission of varicella-vaccine virus from a healthy 12-month-old child to
his pregnant mother.
J Pediatr.
1997;
131
151-4
Reference Ris Wihthout Link
- 17
Sauerbrei A, Glück B, Jung K. et al .
Congenital skin lesions caused by intrauterine coxsackievirus B3 infection:
a case report.
Infection.
2000;
28
326-8
Reference Ris Wihthout Link
- 18
Sauerbrei A, Müller D, Eichhorn U. et al .
Detection of varicella-zoster virus in congenital varicella syndrome: A case
report.
Obstet Gynecol.
1996;
88
687-9
Reference Ris Wihthout Link
- 19
Sauerbrei A, Pawlak J, Luger C. et al .
Intracerebral VZV reactivation in congenital varicella syndrome? A case report.
Dev Med Child Neurol.
2003;
45
837-40
Reference Ris Wihthout Link
- 20
Sauerbrei A, Wutzler P.
The congenital varicella syndrome.
J Perinatol.
2000;
20
548-54
Reference Ris Wihthout Link
- 21
Sauerbrei A, Wutzler P.
Neonatal varicella.
J Perinatol.
2001;
21
545-9
Reference Ris Wihthout Link
- 22
Scharf A. et al .
Virus detection in the fetal tissue of a premature delivery with congenital
varicella syndrome: a case report.
J Perinatol Med.
1990;
18
317-22
Reference Ris Wihthout Link
- 23
Shields K E, Galil K. et al .
Varicella vaccine exposure during pregnancy: data from the first 5 years of
the pregnancy registry.
Obstet Gynecol.
2001;
98
14-9
Reference Ris Wihthout Link
- 24
Spranger S, Stute H, Blankenagel A. et al .
MIDAS-Syndrom - Eine X-chromosomale Erkrankung. Differenzialdiagnose zum kongenitalen
Varizellensyndrom.
Monatsschr Kinderheilkd.
1998;
146
761-5
Reference Ris Wihthout Link
- 25
Verstraelen H. et al .
Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome.
Prenat Diagn.
2003;
23
705-9
Reference Ris Wihthout Link
- 26
Zieger W, Friese K, Weigel M. et al .
Varizellen-Infektion am Geburtstermin.
Z Geburtshilfe Perinatol.
1994;
198
134-7
Reference Ris Wihthout Link
1 Der Beitrag „Varizellen in der Schwangerschaft. Teil 1: Epidemiologie und Klinik” ist im vorhergehenden Heft (Nr. 38) erschienen.
Priv.-Doz. Dr. Andreas Sauerbrei
Institut für Virologie und Antivirale Therapie, Friedrich-Schiller-Universität
Jena
Hans-Knöll-Straße 2
D-07745 Jena
Phone: 0 36 41-65 73 00
Fax: 0 36 41-65 73 01
Email: Andreas.Sauerbrei@med.uni-jena.de